181 related articles for article (PubMed ID: 31994895)
1. Lower respiratory tract delivery, airway clearance, and preclinical efficacy of inhaled GM-CSF in a postinfluenza pneumococcal pneumonia model.
Umstead TM; Hewage EK; Mathewson M; Beaudoin S; Chroneos ZC; Wang M; Halstead ES
Am J Physiol Lung Cell Mol Physiol; 2020 Apr; 318(4):L571-L579. PubMed ID: 31994895
[TBL] [Abstract][Full Text] [Related]
2. GM-CSF overexpression after influenza a virus infection prevents mortality and moderates M1-like airway monocyte/macrophage polarization.
Halstead ES; Umstead TM; Davies ML; Kawasawa YI; Silveyra P; Howyrlak J; Yang L; Guo W; Hu S; Hewage EK; Chroneos ZC
Respir Res; 2018 Jan; 19(1):3. PubMed ID: 29304863
[TBL] [Abstract][Full Text] [Related]
3. Local delivery of GM-CSF protects mice from lethal pneumococcal pneumonia.
Steinwede K; Tempelhof O; Bolte K; Maus R; Bohling J; Ueberberg B; Länger F; Christman JW; Paton JC; Ask K; Maharaj S; Kolb M; Gauldie J; Welte T; Maus UA
J Immunol; 2011 Nov; 187(10):5346-56. PubMed ID: 22003204
[TBL] [Abstract][Full Text] [Related]
4. Delivery of GM-CSF to Protect against Influenza Pneumonia.
Subramaniam R; Hillberry Z; Chen H; Feng Y; Fletcher K; Neuenschwander P; Shams H
PLoS One; 2015; 10(4):e0124593. PubMed ID: 25923215
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
[TBL] [Abstract][Full Text] [Related]
6. GP96 Drives Exacerbation of Secondary Bacterial Pneumonia following Influenza A Virus Infection.
Sumitomo T; Nakata M; Nagase S; Takahara Y; Honda-Ogawa M; Mori Y; Akamatsu Y; Yamaguchi M; Okamoto S; Kawabata S
mBio; 2021 Jun; 12(3):e0326920. PubMed ID: 34061598
[TBL] [Abstract][Full Text] [Related]
7. Inhaled GM-CSF in neonatal mice provides durable protection against bacterial pneumonia.
Todd EM; Ramani R; Szasz TP; Morley SC
Sci Adv; 2019 Aug; 5(8):eaax3387. PubMed ID: 31453341
[TBL] [Abstract][Full Text] [Related]
8. Effect of priming polymorphonuclear leukocytes with cytokines (granulocyte-macrophage colony-stimulating factor [GM-CSF] and G-CSF) on the host resistance to Streptococcus pneumoniae in chinchillas infected with influenza A virus.
Abramson JS; Hudnor HR
Blood; 1994 Apr; 83(7):1929-34. PubMed ID: 7511443
[TBL] [Abstract][Full Text] [Related]
9. Tyk2 as a target for immune regulation in human viral/bacterial pneumonia.
Berg J; Zscheppang K; Fatykhova D; Tönnies M; Bauer TT; Schneider P; Neudecker J; Rückert JC; Eggeling S; Schimek M; Gruber AD; Suttorp N; Hippenstiel S; Hocke AC
Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28705941
[TBL] [Abstract][Full Text] [Related]
10. G-CSFR antagonism reduces neutrophilic inflammation during pneumococcal and influenza respiratory infections without compromising clearance.
Wang H; Aloe C; Wilson N; Bozinovski S
Sci Rep; 2019 Nov; 9(1):17732. PubMed ID: 31776393
[TBL] [Abstract][Full Text] [Related]
11. GM-CSF knockout mice for preclinical testing of agents with antimicrobial activity against Mycobacterium abscessus.
De Groote MA; Johnson L; Podell B; Brooks E; Basaraba R; Gonzalez-Juarrero M
J Antimicrob Chemother; 2014 Apr; 69(4):1057-64. PubMed ID: 24222613
[TBL] [Abstract][Full Text] [Related]
12. TLR4-dependent GM-CSF protects against lung injury in Gram-negative bacterial pneumonia.
Standiford LR; Standiford TJ; Newstead MJ; Zeng X; Ballinger MN; Kovach MA; Reka AK; Bhan U
Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(5):L447-54. PubMed ID: 22160309
[TBL] [Abstract][Full Text] [Related]
13. Alveolar epithelial cells orchestrate DC function in murine viral pneumonia.
Unkel B; Hoegner K; Clausen BE; Lewe-Schlosser P; Bodner J; Gattenloehner S; Janßen H; Seeger W; Lohmeyer J; Herold S
J Clin Invest; 2012 Oct; 122(10):3652-64. PubMed ID: 22996662
[TBL] [Abstract][Full Text] [Related]
14. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice.
Reed JA; Ikegami M; Cianciolo ER; Lu W; Cho PS; Hull W; Jobe AH; Whitsett JA
Am J Physiol; 1999 Apr; 276(4):L556-63. PubMed ID: 10198353
[TBL] [Abstract][Full Text] [Related]
15. GM-CSF in the lung protects against lethal influenza infection.
Huang FF; Barnes PF; Feng Y; Donis R; Chroneos ZC; Idell S; Allen T; Perez DR; Whitsett JA; Dunussi-Joannopoulos K; Shams H
Am J Respir Crit Care Med; 2011 Jul; 184(2):259-68. PubMed ID: 21474645
[TBL] [Abstract][Full Text] [Related]
16. GM-CSF modulates pulmonary resistance to influenza A infection.
Sever-Chroneos Z; Murthy A; Davis J; Florence JM; Kurdowska A; Krupa A; Tichelaar JW; White MR; Hartshorn KL; Kobzik L; Whitsett JA; Chroneos ZC
Antiviral Res; 2011 Nov; 92(2):319-28. PubMed ID: 21925209
[TBL] [Abstract][Full Text] [Related]
17. The effect of aerosolized recombinant human granulocyte macrophage colony-stimulating factor on lung leukocytes in nonhuman primates.
Rose RM; Kobzik L; Dushay K; Wolfthal S; Hondalus M; Metzger M; Stoudemire J; Brain JD; Garnick M; O'Donnell C
Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1279-86. PubMed ID: 1443885
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances pulmonary defenses against pneumococcal infections after splenectomy.
Hebert JC; O'Reilly M
J Trauma; 1996 Oct; 41(4):663-6. PubMed ID: 8858025
[TBL] [Abstract][Full Text] [Related]
19. Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding.
Nita-Lazar M; Banerjee A; Feng C; Amin MN; Frieman MB; Chen WH; Cross AS; Wang LX; Vasta GR
Mol Immunol; 2015 May; 65(1):1-16. PubMed ID: 25597246
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia.
van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Florquin S; Shimizu T; Ishii S; Jansen HM; Lutter R; van der Poll T
Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L194-9. PubMed ID: 16100290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
